Coloplast B A/S

Coloplast A/S develops and sells intimate healthcare products and services globally. It operates through multiple segments, including Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care. The company offers various ostomy care products, continence care products, wound care products, skin care products, and voice and respiratory care solutions. Its product portfolio includes SenSura Mio, Conveen Active, SpeediCath, Peristeen Plus, Biatain Silicone, Comfeel, and InterDry, among others. Coloplast also develops and markets products for the surgical treatment of urological and gynecological disorders. The company was founded in 1954 and is headquartered in Denmark.

Overview

Sector

Medical Instruments & Supplies

Target Price

19.2 DKK

Current Price

613.0 DKK

Potential

-97%

Strengths

Strong EBITDA Margin of 31.18%.

Weaknesses

With a depreciation Potential of -96.94%, based on our fundamental analysis, it suggests the stock may be overvalued.
Price to book ratio (7.88) is significantly higher than the sector mean (3.86).
The company has high debt. Net Debt to EBITDA Ratio (2.47) is higher than the sector mean.
The Price to Free Cash Flow ratio (99.62) is significantly higher than the sector mean.

Key Financial Data

Indicator	Value
PER	27.3
EV/EBITDA	18.9
Price/Free Cash Flow'	97.3
ROIC	7.0%
Net Debt/EBITDA	2.5